Crossmark

The Beneficial Clinical Effects of Teriflunomide in Experimental Autoimmune Myasthenia Gravis and the Investigation of the Possible Immunological Mechanisms

Crossref DOI link: https://doi.org/10.1007/s10571-022-01286-5

Published Online: 2022-10-11

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koseoglu, Emel https://orcid.org/0000-0001-9620-9949
Sungur, Neslihan https://orcid.org/0000-0001-9860-4010
Muhtaroglu, Sabahattin https://orcid.org/0000-0002-5644-2620
Zararsiz, Gokmen https://orcid.org/0000-0001-5801-1835
Eken, Ahmet https://orcid.org/0000-0002-0721-6213
Funding

Funding for this research was provided by:

Bilimsel Araştırma Projeleri, Erciyes Üniversitesi (TDK-2019-9670)
License Information

Text and Data Mining valid from 2022-10-11

Version of Record valid from 2022-10-11
More Information

Article History

Received: 30 June 2022

Accepted: 14 September 2022

First Online: 11 October 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below